Cytodyn Inc (CYDY)

[woodenbear]

#3 is spot on here. Until the company has an alternative to issuing cheap shares and warrants, “smart” investors will keep going back to the well. Those investors are largely the same on iterative rounds - Paulson Investors and others. Meaning the same investors are consciously and intentionally buying more and more. As a result, SP stays suppressed just above our buy in point bc we can still take a small profit. Not bc we don’t believe in the company but bc we know we can recycle that back into the company and stock pile warrants at the next raise. We take no real risk of “missing out” bc we hold warrants.

THIS IS SO MUCH SIMPLER THAN THIS BOARD IS TRYING TO MAKE IT. The argument and paranoia that the stale SP is bc “smart” investors are able to sniff something out that you can’t is naive when you consider the fact that the company has been able to continue to raise many from the same place over so many years. The stale SP is simply the result of supply and demand. Econ 101. The only problem here is anyone with substantial money to invest is going straight to the company, instead of being force to the OTC.

The only question that is left is why hasn’t a deal been struck. No one but CYDY or BP can know that. But it probably has to do with the fact that cancer was just added to this company last fall and the full potential is unknown. NP has made it clear he wants full value and as we all know that could be astronomical.